- Model Tripartite Agreement between the Issuer, Existing Share Transfer Agent and New Share Transfer Agent (PDF - 126.9KB)
- Intimation of Record Date pursuant to Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (PDF - 165.4KB)
- Related Party Transactions for March 2023 (PDF - 306.7KB)
- Outcome of Board Meeting - May 2023 (PDF - 1,001.9KB)
- Media release: Q4 & FY22-23 (PDF - 259.5KB)
- Board Meeting Intimation - 3rd May 2023 (PDF - 155.9KB)
- Trading Window Closure March 2023 (PDF - 155.3KB)
- Transcript of Analyst / Institutional Investor Meetings (PDF - 757.3KB)
- Outcome of Schedule of Analyst / Institutional Investor Meetings (PDF - 1.7MB)
- Disclosure under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (PDF - 176.2KB)
- Intimation of Schedule of Analyst / Institutional Investor Meetings under the Listing Regulations (PDF - 170.8KB)
- Media release: Q3 of 2022-23 (PDF - 461.0KB)
- Unaudited (Standalone and Consolidated) financial results for the third quarter & nine months 31st December 2022 (PDF - 2.2MB)
- Disclosure under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (PDF - 176.8KB)
- Board Meeting Intimation - 11th January 2023 (PDF - 176.6KB)
- Trading Window Closure December 2022 (PDF - 131.2KB)
- Disclosure under Regulation 30(5) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (PDF - 178.2KB)
- RPT For Half Year Ended September 2022 (PDF - 501.2KB)
- Press Release November 2022 (PDF - 277.0KB)
- Board Meeting Intimation - 31st October 2022 (PDF - 176.8KB)
- Outcome Of Meeting November 2022 (PDF - 2.9MB)
- Outcome of Board Meeting - Change in Directorate - 17th October 2022 (PDF - 619.6KB)
- Closure of Trading Window for Trading in GSK Pharma Shares Directors (PDF - 156.2KB)
- Presentation for Analyst Meet - August 24, 2022 (PDF - 1.2MB)
- Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations - August 19, 2022 (PDF - 336.0KB)
- Outcome of meeting - Change in Directortate (PDF - 323.1KB)
- Un-Audited Financial Results for the first quarter ended 30th June 2022 (PDF - 128.2KB)
- Closure of Trading Window - June 28, 2022 (PDF - 149.9KB)
- Notice to shareholders of the Company holding shares in physical form with regard to norms for furnishing PAN, KYC details and Nomination (PDF - 235.7KB)
- Change In Directorate Mark Dawson (PDF - 137.8KB)
- Submission of Disclosure on Related Party Transactions - May 30, 2022 ( - )
- Secretarial Compliance Report 2022 (PDF - 468.2KB)
- Media Release Q4 & FY21 22 (PDF - 354.5KB)
- Outcome of the Board Meeting - May 16, 2022 (PDF - 852.0KB)
- Disclosure Under Regulation 30(5) of the SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 (PDF - 291.1KB)
- Completion of Sale of Company's trademarks 'pertaining to 'lodex' and 'Ostocalcium' Brands in India (PDF - 264.3KB)
- Change in Directorate - February 07, 2022 (PDF - 223.6KB)
- Media release: Q3 of 2021-22 (PDF - 375.1KB)
- Unaudited (Standalone and Consolidated) financial results for the third quarter and nine months ended 31st December 2021 ( - )
- Related Party Transaction as on September 30, 2021 (PDF - 70.5KB)
- Completion of Sale of Company’s Manufacturing Facility located at Vemgal, Karnataka (PDF - 110.4KB)
- Change in Directorate (PDF - 470.0KB)
- Change in email ID for Investor Communication (PDF - 210.0KB)
- Analyst Meet November 2021 (PDF - 270.5KB)
- Outcome of the board meeting on October 29, 2021 (PDF - 361.0KB)
- Media release: Quarter ended September 30, 2021 (PDF - 456.9KB)
- Statement of Standalone Unaudited Financial Results for the Quarter and Six Months ended 30th September, 2021 (PDF - 1.7MB)
- Statement of Consolidated Unaudited Financial Results for the Quarter and Six Months ended 30th September, 2021 (PDF - 2.0MB)
- Board Meeting Intimation - Un-Audited Financial Results for the second quarter and half year ended 30th September 2021 (PDF - 135.2KB)
- Trading window closure - October 2021 (PDF - 139.9KB)
- Presentation of Analyst/ Institutional Investor Meetings (PDF - 2.5MB)
- Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations - Aug 11, 2021 (PDF - 176.0KB)
- Media release: Q1 of 2021-22 (PDF - 397.2KB)
- Outcome of the Board Meeting - July 26, 2021 (PDF - 2.7MB)
- Outcome of Board Meeting - July 26, 2021 (PDF - 227.1KB)
- Un-Audited Financial Results for the first quarter ended 30th June 2021 (PDF - 208.8KB)
- Closure of 'Trading Window' (PDF - 226.0KB)
- Intimation of Record Date pursuant to Regulation 42 of the Securities and Exchange Board of India (LODR) Regulations, 2015 (PDF - 95.3KB)
- Outcome of meeting - May 18, 2021 (PDF - 1.1MB)
- Press release - May 2021 (PDF - 183.5KB)
- Trading window closure (PDF - 221.2KB)
- Media release: Q3 and FY20-21 (PDF - 454.7KB)
- Outcome of Board Meeting - February 05, 2021 (PDF - 1.6MB)
- Resignation Letter (PDF - 223.1KB)
- Change in Directorate - January 11, 2021 (PDF - 356.8KB)
- Un-Audited Financial Results for the quarter and nine months ended 31st December 2020 (PDF - 131.9KB)
- Closure of Trading Window - December 28, 2020 (PDF - 230.0KB)
- Media release: Q2 FY20-21 (PDF - 217.4KB)
- Outcome of Board Meeting - October 2020 (PDF - 1.4MB)
- Un-Audited Financial Results for the quarter and six months ended 30th September 2020 (PDF - 262.9KB)
- Closure of Trading Window (PDF - 249.8KB)
- Intimation of Schedule of Analyst / Institutional Investor Meetings under the Listing Regulations - September 18, 2020 (PDF - 260.3KB)
- Outcome of Board meeting - July 29, 2020 ( - )
- Disclosure of Voting Results and Outcome of the 95th Annual General Meeting of the Company (PDF - 1.1MB)
- Discontinuation of supply of Ranitidine products (PDF - 134.2KB)
- Media release: Q4 FY19-20 (PDF - 101.2KB)
- Outcome of the Board Meeting - May 18, 2020 ( - )
- Outcome of Board Meeting March 2020 (PDF - 704.0KB)
- Press release - New MD appointment (PDF - 477.9KB)
- GSK Analysts' Meet 2020 (PDF - 522.8KB)
- Unaudited (Standalone and Consolidated) financial results for the third quarter and nine months ended 31st December 2019 (PDF - 1.8MB)
- Media release: Quarter ended 31st December 2019 (PDF - 851.4KB)
- Trading window closure February 2020 (PDF - 245.2KB)
- Board Meeting Intimation February 2020 (PDF - 232.7KB)
- Outcome of Board Meeting October 2019 (PDF - 3.7MB)
- Intimation of Schedule of Analyst / Institutional Investor Meetings under the Listing Regulations (PDF - 247.4KB)
- Submission of Disclosure on Related Party Transactions (PDF - 739.7KB)
- Trading window closure October 2019 (PDF - 216.7KB)
- Board Meeting Intimation October 2019 (PDF - 208.9KB)
- Update on the Company's Ranitidine Product (PDF - 412.2KB)
- Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations - September 5, 2019 (PDF - 259.3KB)
- Approval of Sale of Company's land at Thane, Maharashtra 30/8 - August 30, 2019 (PDF - 291.3KB)
- Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations - August 12, 2019 (PDF - 257.5KB)
- Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations - August 12, 2019 (1) (PDF - 258.3KB)
- Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations - August 1, 2019 (PDF - 285.8KB)
- Outcome of Board Meeting July 2019 (PDF - 2.6MB)
- Outcome of AGM (PDF - 5.3MB)
- Outcome of Board Meeting - May 2019 (PDF - 3.0MB)
- Intimation of Book Closure 2019 (PDF - 319.9KB)
- Board Meeting Intimation - May 20, 2019 (PDF - 248.7KB)
- Change in Directorate - March 28, 2019 (PDF - 985.9KB)
- Outcome of the Board Meeting - February 04, 2019 (PDF - 1.5MB)
- Board Meeting Intimation - February 4, 2019 (PDF - 208.9KB)
- Board Meeting Intimation - Oct 2018 (PDF - 137.9KB)
- Publication of Add of Record Date for Bonus Issue of Shares (PDF - 792.2KB)
- Record Date for Bonus Issue of Equity Shares (PDF - 282.7KB)
- Outcome of AGM - July 24, 2018 (PDF - 511.9KB)
- Outcome of Board Meeting - July 24, 2018 (PDF - 1.3MB)
- Board Meeting Intimation - July 24, 2018 (PDF - 227.2KB)
- Notice of Book Closure - May 24, 2018 (PDF - 342.8KB)
- Board Meeting Intimation - May 24, 2018 (PDF - 252.3KB)
- Board Meeting Intimation - February 02, 2018 (PDF - 256.7KB)
- Change in Directorate - October 25, 2017 (PDF - 354.3KB)
- Board Meeting Intimation - October 25, 2017 ( - )
- Outcome of AGM 2017 and Voting Results (PDF - 3.3MB)
- Board Meeting Intimation - July 25, 2017 (PDF - 243.7KB)
- Publication of Evoting and Book Closure Notice (PDF - 4.8MB)
- IEPF Notice - May 24, 2017 (PDF - 487.4KB)
- Notice of Book Closure (PDF - 38.0KB)
- Board Meeting Intimation - May 19, 2017 (PDF - 38.7KB)
- Disclosures of castleton and GSK PTE (PDF - 148.1KB)
- Change in Directorate - April 07, 2017 (PDF - 96.5KB)
- Board Meeting Intimation - February 11, 2017 (PDF - 39.5KB)
- IEPF notice (PDF - 2.5MB)
- Notice of Board Meeting - October 27, 2016 (PDF - 39.0KB)
- Outcome of AGM and Voting Results (PDF - 1.3MB)
- Notice of Business Meeting - July 28, 2016 (PDF - 531.8KB)
- Publication of Notice regarding e-voting in Newspapers (PDF - 334.6KB)
Notices
Notices relevant to our shareholders are listed here. View our Un-Audited Financial Results, Disclosures, Media Releases, Outcome of the Board Meetings and other notices here.
